Journal Home
Search for

Volume 63, Issue 4, Pages e364-e369 (April 2010)


View previous. 26 of 53 View next.

The effect of growth hormone on fibroblast proliferation and keratinocyte migration

Sang Woo Lee, Suk Hwa Kim, Ji Youn KimCorresponding Author Informationemail address, Yoonho Lee

Received 30 March 2009; accepted 22 October 2009. published online 21 December 2009.

Summary 

Background

The beneficial effects of growth hormones (GHs) on wound healing have been reported. Although the mechanism of how GH promotes wound healing is unclear, there are reports showing that the principal factor lies in the GH-stimulated production of IGF-1 in topical wounds. In this study, a human primary cell model was devised to examine how the topical application of GHs affects fibroblast proliferation and keratinocyte migration, which play fundamental roles in wound healing.

Methods

The fibroblasts were cultured in media with different concentrations of GH. The amount of fibroblast proliferation was assessed using a tetrazolium-based colourimetric assay (MTT assay). The amount of newly formed IGF-I mRNA was measured by reverse transcription and polymerase chain reaction (RT-PCR). Keratinocyte migration was compared using a migration assay.

Results

Fibroblast proliferation was significantly higher in the experimental group than in the control group (the absorbance of 2.5IU L−1 GH applied group: 0.3954±0.056, control group: 0.2943±0.0554, P<0.05), and the promotion of IGF-I formation by fibroblasts was observed. There was more keratinocyte migration in the experimental group than in the control group (the remaining gap in the 2.5IU L−1 GH applied group after keratinocyte migration: 46.57±2.22% of the primary gap, control group: 75.14±3.44%, P<0.05).

Conclusion

GH enhances the local formation of IGF-1, which activates fibroblast proliferation and keratinocyte migration. These results highlight the potential of the topical application of GHs in the treatment of wounds.

Department of Plastic and Reconstructive Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea

Corresponding Author InformationCorresponding author. Tel.: +82 10 6256 0126.

PII: S1748-6815(09)00752-9

doi:10.1016/j.bjps.2009.10.027


View previous. 26 of 53 View next.